A carregar...
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
Oncolytic virus (OV) therapy utilizes replication-competent viruses to kill cancer cells, leaving non-malignant cells unharmed. With the first U.S. Food and Drug Administration-approved OV, dozens of clinical trials ongoing, and an abundance of translational research in the field, OV therapy is pois...
Na minha lista:
| Publicado no: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415316/ https://ncbi.nlm.nih.gov/pubmed/28480326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2017.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|